| Investor Type | Firm |
| Investing | Netherlands |
| Investment Range | $6,300,000 - $55,000,000 |
Merck Ventures, known as M Ventures, is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany. Founded in 2009, the fund operates with an allocation of 600 million euros and is focused on investing in transformational ideas across Biotechnology and Technology.
The fund is particularly interested in covering areas such as Healthcare drug development, Life Science tools, Electronics, and Frontier Technology & Sustainability.
With both strategic and financial objectives, M Ventures invests in visionary companies that are developing solutions to treat challenging diseases, empower scientists with innovative research and development tools, as well as create new solutions in information technology and sustainability.
They take an active role in their portfolio companies, collaborating with entrepreneurs and co-investors to drive innovation towards commercial success. Additionally, the firm is involved in company creation, including the creation of spin-offs to leverage Merck's science and technology base.
Their investment thesis revolves around identifying and nurturing companies that have the potential to make a significant impact on Merck's core business areas. M Ventures positions itself as a founder-friendly investor, extending support to their portfolio companies, exemplified in the fields of immunotherapy, semiconductor and OLED technology, AI and ML data science, and more.
The firm's minimum investment size is typically around 6.3 million euros, going up to a maximum of 55 million euros for transactions.

